This country profile provides an overview of Mozambique’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Mozambique
- Mozambique is commended for the leadership demonstrated by the Government, with the recent announcement by the Prime Minister of US$6M in domestic resources for NTDs.
- With these resources, Mozambique is encouraged to work to clarify the epidemiology of river blindness in the country.
- Further, it should work to identify the reasons for the fluctuating coverage rates for bilharzia, intestinal worms and trachoma and systematically work to address the issues identified.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage increased from 74% in 2016 to 80% in 2017.
Treatment coverage decreased from 45% in 2016 to 0% in 2017.
Treatment coverage increased from 57% in 2016 to 87% in 2017.
Treatment coverage decreased from 93% in 2016 to 32% in 2017.
Mozambique does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mozambique.